chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12/6/2022 I began, around 8:00PM, with a headache and then chills. I woke up the next morning with body aches, congestion and headache. This lasted most of the day. I begin coughing during the day. On 12/7/22, I tested positive for COVID with an at home test. I called my doctor and made an appointment. 12/8/22, I had a telehealth appointment and was prescribed PAXLOVID. I began taking it that evening. My symptoms all lasted through Thursday, 12/8/22. Since then, it has gotten better each day. I am just experiencing being extra tired for the past few days. My last dose of PAXLOVID was 12/14/22.
Initial report received on 29 September 2011 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a six month old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance System electronic database. The subject's vaccine history included 3 doses of PENTACEL; lot number C3734AB received on 15 March 2011, PENTACEL (lot number not reported) received on 12 May 2011 and lot number C3879AA received on 12 July 2011 (routes and sites of administration not reported). The subject developed cold-like symptoms and cough on 07 August 2011, approximately 26 days after the last dose. On 14 August 2011, the subject developed a paroxysmal cough with a whoop. The subject did not experience any posttussive vomiting, apnea or sleep disturbance. Laboratory testing included positive PCR on 17 August 2011. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 17 August 2011 for 5 days. The subject was not hospitalized. At the time of final contact on 12 September 2011, the subject's cough was resolved. The duration of the cough was reported at that time as 18 days. According to the investigator, this case was epidemiologically linked to a laboratory confirmed case. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Patient given VARICELLA & MENACTRA vaccinations and after he walked into lobby he passed out.  Patient set in wheelchair & assisted by Dr. .  BP 60/33 - Pt wheeled to room and left to rest on table.  Patient walked out w/o problems w/dad and BP was 99/66.
Little nervous; infection from the red tide; cardiac problems/ pulse is running really low/ problem with a lower pulse/ pulse dips down to 32, 34 beats per minute/ pulse was 34; He doesn't want to go to sleep and not wake up; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (cardiac problems/ pulse is running really low/ problem with a lower pulse/ pulse dips down to 32, 34 beats per minute/ pulse was 34), NERVOUSNESS (Little nervous), FEELING ABNORMAL (He doesn't want to go to sleep and not wake up) and INFECTION (infection from the red tide) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 022B21A) for COVID-19 vaccination.     The patient's past medical history included Block heart and Stent placement.   On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2021, the patient experienced CARDIAC DISORDER (cardiac problems/ pulse is running really low/ problem with a lower pulse/ pulse dips down to 32, 34 beats per minute/ pulse was 34) and FEELING ABNORMAL (He doesn't want to go to sleep and not wake up). On 05-Sep-2021, the patient experienced INFECTION (infection from the red tide). On an unknown date, the patient experienced NERVOUSNESS (Little nervous). At the time of the report, CARDIAC DISORDER (cardiac problems/ pulse is running really low/ problem with a lower pulse/ pulse dips down to 32, 34 beats per minute/ pulse was 34), NERVOUSNESS (Little nervous), FEELING ABNORMAL (He doesn't want to go to sleep and not wake up) and INFECTION (infection from the red tide) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electrocardiogram: normal (normal) normal. In June 2021, Heart rate: 32 (Low) 32 beats per minute. In September 2021, Heart rate: 34 (Low) 34 beats per minute.         Concomitant information was not provided.  The patient was treated with IV antibiotic for about 6 weeks for the infection. Patient reports no other treatment taken in addition to this.  It was reported that the patient was instructed to insert the pacemaker as a part of correction procedure and patient confirms that patient doesn't have atrial fibrillation.
p/vax pt exp pain/swelling @ inj site; rt side induration & heat; swollen fingers & pain in joints of fingers;MD felt react was localized; tx: prednisone & valtrex; pt rpt exp flare-up of lupus w/arthritis & joint pain;
This case was reported by a other health professional and described the occurrence of expired vaccine used in a male patient who received ENGERIX B (batch number unknown, expiry date 6th September 2014). On 22nd September 2014, the patient received ENGERIX B. On an unknown date, an unknown time after receiving ENGERIX B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. It was unknown if the reporter considered the expired vaccine used to be related to ENGERIX B.
Rash around Right eye and spreading to cheek and forehead.  Rash is red papules with pustules as well.  Itchy.  No other inciting events
Chills 13-24 hrs after jab Fever (99.4F) 24 hrs after jab Headache 18-28 hrs after jab
Breakthrough COVID symptoms- nausea, fever, vomiting, diarrhea, loss of smell and test one month after second vaccine
ADVERSE REACTIONS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced adverse reactions. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse reactions was not reported. This report was non-serious.
Administered influenza IM to right arm, then administered Pneumovax 23 IM to left arm.  Patient bled on Pneumovax injection, leaked thru Inject-Safe barrier bandage. Applied pressure and paper towel, patient stopped bleed in about 3 minutes.  Applied new bandage to injection site, no further bleeding.  Advised patient on use of cold water to dissolve blood drip on pants. Patient had no other problems at time of injection, felt fine.  Patient released to home.  contacted patient 9/7/19 to inquire of any problems, was informed by daughter that patient had started feeling ill around 2200 9/6/19, with pain, red ring around injection site and swelling extending into shoulder.  Daughter took patient to local emergency center for treatment.  ER treated patient and released back to home evening of 9/6/19.  on 9/7/19 at time of call, patient improving, swelling down some, still having pain from injection.  Daughter treating with ibuprofen.
Heavy menstrual bleeding for 18 days after first vaccination; This is a spontaneous report from a contactable other hcp (patient/nurse). A 53-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6206, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 16Mar2021 13:15 as DOSE 1, SINGLE for covid-19 immunization (53 year when vaccinated) at Pharmacy or Drug Store.  Medical history included asthma from an unknown date, anaemia from an unknown date, drug hypersensitivity from an unknown date (allergy from sulfa and PCN). The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. On an unknown date in Mar2021, the patient developed heavy menstrual bleeding for 18 days after first vaccination. The patient did not receive any treatment for the event. The patient had to visit doctor due to the event. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was reported as recovered.  No follow-up attempts are possible. No further information is expected.
low-grade fever, chills,  malaise, systemic muscle aches, mild abdomenal pain.  Tylenol OTC q 4-6 hr.
pt recv vax 27NOV95 & 8SEP97 pt exp chickenpox consisting of approx 30-40 lesions on the hands, buttocks, legs, & feet;pt also exp a sl fever;
50 y/o female, past medical history of Adult Onset Diabetes and Hypercholesterolemia who presents with dry throat and itchy rash to her neck and abdomen onset post vaccination. Patient states that this is her second dose in 2 dose series. Patient denies previous reaction to vaccinations. NP and Paramedics at patient side. A red, macular rash was noted to the anterior neck. Patient provided a bottle of water and 25mg of Benadryl PO x1. Patient vitals obtained, patient noted with slightly elevated BP (157/94) and all other vitals within normal limits (99% RA, 87 HR, 12 Resp). Glucose was noted to be 165, patient discloses that she didn?t eat or take her Metformin this am. Patient provided with a protein bar and took her pending dose of Metformin. Patient was observed by the NP and Paramedics for 20 minutes with resolution of symptoms, rash resolved and no further complaints of throat irritation. Patient cleared to go home and aware of concerning signs and symptoms that would necessitate further evaluation by emergency providers.
Nine days after injection a red 1 inch circle appeared at shot site.  Next day it double in size. It continued to get bigger each day for seven days.  It was red and itchy over whole area.  It grew to 3 inches wide by 4 inches long .  By the seventh day the redness began to subside as did the itching.  Went to doctor on 1/29/2021 which was the seventh day and she prescribed  topical  Triamcinolone Acetonide Cream and ice .  As of today the  eight day, the area  was less  red  and was blotchy  with less itching.
As soon as vaccine was given, I turned to put syringe in sharps container; and patient fell out of chair to the floor.
expired Moderna vaccine administered to patients; The vial was initially stored in the refrigerator on 5-Apr-2022, Administered between 6-Apr-2022 to 9-Apr-2022, which was expired on 1-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 5-Apr-2022, Administered between 6-Apr-2022 to 9-Apr-2022, which was expired on 1-Apr-2022) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 5-Apr-2022, Administered between 6-Apr-2022 to 9-Apr-2022, which was expired on 1-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 5-Apr-2022, Administered between 6-Apr-2022 to 9-Apr-2022, which was expired on 1-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. It was reported that the administration occurred from 6-Apr-2022 to 9-Apr-2022. The vial was initially stored in the refrigerator on 5-Apr-2022 The vial had not undergone any temperature excursions.  It was also reported that patients had not reported any adverse reactions No treatment medication information was given.   This case was linked to MOD-2022-538688, MOD-2022-538614 (Patient Link).
Information has been received from a reporter who mentioned that he heard of a boy in a family was vaccinated with one dose of MMR II on an unspecified date. One or two weeks later, the boy was diagnosed with autism. At the time of this report, the patient was not recovered. It was not specified if the patient sought medical attention or not. The reporter also heard another boy in the family was diagnosed with autism after receiving MMR II (MSD) (WAES#0903USA04509). Upon internal review, autism was considered to be other important medical event. Follow-up information could not be obtained to verify the existence of an identifiable patient.
When billing vaccine to insurance, it says patient already received flu vaccine on 8/29/23.
Patient given Pfizer Bi-Valent booster indicated above. Patient only received 1st dose  from Pharmacy on 08/03/2021, verified through Links.
Patient arrived to community vaccination clinic with Mom and annual flu shot given without incident. Pfizer Bivalent  5 -11 year old booster was administered without being diluted. Patient received 0.2 cc of undiluted Pfizer Bivalent booster @ about 3:30 pm. Vaccination error noted around 5:30 pm on 12/1/22. This RN called mom - on 12/2/22 @ 11:15 am.  Mom was informed re: medication error and aware that this RN would call and follow up with pediatrician. Mom reports that Patient has slight cough and some sneezing over night (12/1) but woke up and went to school as scheduled.  Mom instructed to encourage water for the rest of 12/2 with patient.  Nurse from Dr.'s office made return call to this RN @ 2 pm on 12/2 and instructed RN to have Mom continue to monitor patient closely today and over the weekend. No prn medications ordered, Mom to call MD if patient develops any unusual symptoms.
Arms swollen.  Patient was advised to take benadryl the night of 7/27/16.  Follow up on 7/28/16 10 Am, the swelling decreased and patient said she is much better now with a little ache.
Information has been received from a registered pharmacist concerning a patient who on an unspecified date was vaccinated a dose of GARDASIL vaccine (yeast) which was stored improperly. The patient has not experienced any known symptoms. It was unspecified if the patient sought medical attention. This is one of several reports from the same source.
3 hours after vaccine (12:45pm) had hives on face and had difficulty breathing. Later that night (7:00pm) ran low fever morning of next day had fever of 106.5° f (4:30am).
Tinnitus It started the day after the shot. It has continued unabated since. It is getting neither better nor worse. The severity is moderate, i.e. I can hear it whenever I'm not involved in some engaging mental activity that distracts me from the ringing. It is not keeping me from engaging in any activities; it is not making me miserable; but it is a significant problem.
Patient noted large area of redness on upper arm on 11/04/2003 (injection was given 10/27/2003). 6 inch length by 2 3/4 inch width.  Non raised.  No other adverse effects noted.
SICK; FEVER; HEADACHE; TIRED; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced sick, fever, headache, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, headache, tired and sick was not reported. This report was non-serious.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug, allergy history or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX (strength, dose, frequency and route of administration were not provided) lot # N026073, expiration date 20-SEP-2019 for prophylaxis. Concomitant therapies included sterile diluent (MRK). The doses of VARIVAX were exposed to a temperature excursion of 6°Fahrenheit (°F) to 14°F (8.8°F) during a time frame of 1 hour and 18 minutes, which was detected by the data logger. There was no previous temperature excursion. No adverse effects were reported. Sender's Comments: US-009507513-1804USA003075: US-009507513-1804USA003064: US-009507513-1804USA003065: US-009507513-1804USA003066: US-009507513-1804USA003067: US-009507513-1804USA003068: US-009507513-1804USA003069: US-009507513-1804USA003070: US-009507513-1804USA003071: US-009507513-1804USA003072: US-009507513-1804USA003073: US-009507513-1804USA003074: US-009507513-1804USA003062: US-009507513-1804USA003063.
SWOLLEN BREAST; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced swollen breast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of swollen breast was not reported. This report was non-serious. This case, from the same reporter is linked to 20220635096 and 20220610772.
Redness and swelling noted around site of vaccination one day after administration. Redness and swelling were worse the second day after vaccine given. Mother reports yellow drainage from vaccine site. Mother gave pt BENADRYL. Mother brought pt to clinic 3 days after vaccine given.  Mild swelling and redness around site to right thigh, Tender to touch. Mother states pt had a fever after vaccines were given. Fever for one day.
Systemic: Fainting / Unresponsive-Mild, Additional Details: EMS Called
This spontaneous case, initially received from a pharmacist on 04-Sep-2018 concerns a 57-year-old, adult, female patient. The patient had no medical history. The patient did not receive any concomitant medication. On 04-Sep-2018, the patient under age of 65 years was accidently administered FLUAD (TIV) [dose: 0.5 ml, anatomical location: left deltoid, route of administration: intramuscular, batch number: 250783 (reported as 2507863), expiry date: 30-Apr-2019]. The Seqirus confirmed that, batch number (250783) was a valid FLUAD batch number. No adverse event or adverse reaction was reported. It was reported that, the patient had a follow up with her primary care physician (PCP). This case was linked to case number: 201803732 reported by the same reporter. Update on 07-Sep-2018: Significant case correction (IRD: 04-Sep-2018): The Seqirus confirmed that, batch number (250783) was a valid FLUAD batch number. Hence, the batch number (250783) of the suspect product was added in the product tab and the narrative was amended accordingly. Non-significant follow up received by reporter on 12-Sep-2018: The patient did not report any adverse event or adverse reaction. The patient had a follow up with her primary care physician (PCP). The narrative was amended accordingly.
Rapid heartbeat. Difficulty breathing. Numbness in right side of face near mouth. Left hand swollen and numb. Slight "balloon head" feeling in back of head.
Headache nauseous ting arm lips scattered rash pm fatigue Vicious Headache sore neck arm sore palpatations fatigue Headache sore arm palpations fatigue  Flulike symptoms 1-6 days
Redness, swelling, warmth right upper arm.  Bright red around injection site, lighter red upper arm down past elbow.  Given rocephin 1 gm IM, Benadryl, keflex PO.
Moderna was given patient is 17 years of age- patient waited 30 min for observation, no symptoms.
On 09/30/2021 I started with a sore throat. The next morning, I woke up with a really bad cold. I was supposed to go on a trip with friends. I got tested for Covid on Saturday. On Sunday the doctor called and said it was positive. I had cough, stuffiness, a lot of congestion, I lost my sense of smell and taste, I had a low-grade fever. Last week I got the infusion and right away my lungs got better. I was having trouble breathing before that. The same week I got sick, I woke up on Monday with blood in my urine and back ache. I went to the doctor and he gave me a referral for a specialist and they determined I had a kidney stone. They discovered I had a UTI. I have recovered from the UTI and kidney stone. I still have symptoms of Covid. My doctor told me that I am not contagious anymore.
acquired TTP (thrombotic thrombocytopenic purpura); This is a spontaneous report from a contactable physician. A 15-years-old male patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via intramuscular route on 10Apr2021, at the age of 15 years, (Batch/Lot Number: Unknown) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior vaccination. On 20Apr2021 the patient experienced acquired thrombotic thrombocytopenic purpura (TTP) which required the patient's hospitalization for 8 days, moreover the BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine was administered to patient of inappropriate age. The acquired TTP was formally diagnosed on 29Apr2021 but symptoms started on 20Apr2021, approximately 10 days after first vaccine dose. On 29Apr2021 the patient underwent lab tests and procedures which included SARS-CoV-2 test via nasal swab which was negative. As a result of acquired TTP the patient was treated with plasmapheresis, corticosteroids and rituximab. The event acquired TTP was resolving at the time of the report.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available a causal relationship between event "acquired thrombotic thrombocytopenic purpura" occurred approximately 10 days after first vaccine dose and BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine cannot be completely excluded.  The case will be reevaluated should additional information become available. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to investigators, as appropriate.
body aches, headache at base of skull, weakness, 100F fever   treated with tylenol
My daughter developed celiac disease symptoms about 4 months after her 3rd dose of HPV vaccine. She never had ANY symptoms before that.
Received Vaccine on 1/8/21, delayed reaction. Rash to left arm, redness,  swollen, hot to touch and itching. Area measures 3 1/2 X 3 1/2.. Also, experiencing headache.